Clinical and pathological features of autoimmune hepatitis-primary biliary cholangitis overlap syndrome versus autoimmune hepatitis

Wang TingTing; Lu ChangLi; Fan XiaoLi; Yang Li

doi:10.3969/j.issn.1001-5256.2017.11.026

Issue 11

Nov. 2017

Turn off MathJax

Article Contents

Abstract

References

Article Navigation > Journal of Clinical Hepatology > 2017 > 33(11): 2179-2185

PDF( 2396 KB)

Clinical and pathological features of autoimmune hepatitis-primary biliary cholangitis overlap syndrome versus autoimmune hepatitis

DOI: 10.3969/j.issn.1001-5256.2017.11.026

Department of Gastroenterology, West China Hospital, Sichuan University

Research funding:

Received Date: 2017-05-02
Published Date: 2017-11-20

Abstract

Abstract

Objective To investigate the clinical and pathological features of autoimmune hepatitis (AIH) -primary biliary cholangitis (PBC) overlap syndrome (AIH-PBC OS) versus AIH, since it is still difficult to diagnose AIH-PBC OS in clinical practice, and to enhance the knowledge of AIH-PBC OS and improve its early diagnostic rate.Methods A prospective study was performed for the clinical data, biochemical and immunological markers, autoantibody, and liver pathology of 50 patients with AIH-PBC OS confirmed by liver biopsy who visited West China Hospital, Sichuan University, from January 20, 2015 to November 28, 2016 and 57 patients with AIH alone, in order to compare the features of AIH-PBC OS and AIH.Continuous data such as laboratory markers were expressed as median M (inter-quartile range) and the nonparametric rank sum test was used for comparison of these data between two groups;categorical data including clinical features、histopathological manifestations were expressed as rates and the chi-square test was used for comparison of these data between two groups.Results The AIH-PBC OS group had a significantly lower age of onset than the AIH group (Z=-1.975, P=0.048) , while there was no significant difference in male/female sex ratio between the two groups.The AIH-PBC OS group had a significantly higher proportion of patients with pruritus than the AIH group (22.0% vs 7.0%, χ2=4.960, P=0.026) .Compared with the AIH group, the AIH-PBC OS group had significantly higher levels of alkaline phosphatase (ALP) , gamma-glutamyl transpeptidase (GGT) , and immunoglobulin M (IgM) (Z=-6.250, -4.789, and-5.407, all P<0.001) , a significantly higher positive rate of antimitochondrial antibody (AMA) (χ2=26.811, P<0.001) , and significantly lower serum levels of alanine aminotransferase (ALT) , aspartate aminotransferase, and immunoglobulin G (IgG) (Z=-2.916, -3.381, and-2.285, P=0.004, 0.001, and 0.022) .The AIH-PBC OS group had significantly higher incidence rates of bile duct injury, bile duct loss, granulomatous disease, and cholestasis than the AIH group (χ2=25.612, 15.953, 6.490, and 10.042, P<0.001, <0.001, 0.001, and 0.002) .Conclusion Although AIH-PBC OS has the features of both AIH and PBC, it is not a simple overlap between AIH and PBC.Pruritus, significant increases in the levels of ALP, GGT, and IgM, positive AMA, and inflammatory bile duct disease and cholestasis may have implications for the diagnos of AIH-PBC OS.Since AIH-PBC OS may have milder liver inflammatory injury and autoimmune abnormalities than AIH, the levels of ALT and IgG in Paris criteria can be broadened during the diagnosis of AIH-PBC OS, in order to prevent missed diagnosis and avoid affecting the selection of treatment regimen and patients' prognosis.
- hepatitis, autoimmune,
- cholangitis, sclerosing,
- pathology, clinical,
- disease attributes

FullText(HTML)

References(22)

References

[1]CHAZOUILLERES O, WENDUM D, SERFATY L, et al.Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome:clinical features and response to therapy[J].Hepatology, 1998, 28 (2) :296.

[2]WOODWARD, NEUBERGER J.Autoimmune overlap syndromes[J].Hepatology, 2001, 33 (4) :994.

[3]SCHRAMM C, LOHSE AW.Overlap syndromes of cholestatic liver diseases and auto-immune hepatitis[J].Clin Rev Allergy Immunol, 2005, 28 (2) :105-114.

[4]European Association for the Study of the Liver.EASL clinical practice guidelines:management of cholestatic liver diseases[J].JHepatol, 2009, 51 (2) :237-267.

[5]BUNCHORNTAVAKUL C, REDDY KR.Diagnosis and management of overlap syndromes[J].Clin Liver Dis, 2015, 19 (1) :81-97.

[6]KRAWITT EL.Autoimmune hepatitis[J].N Eng I J Med, 2006, 354 (1) :54-66.

[7]CHEN CW, CHENG J, DOU XG, et al.Consensus on the diagnosis and management of primary biliary cirrhosis (cholangitis) (2015) [J].J Clin Hepatol, 2015, 20 (12) :960-968. (in Chinese) 陈成伟, 成军, 窦晓光, 等.原发性胆汁性肝硬化 (又名原发性胆汁性胆管炎) 诊断和治疗共识 (2015) [J].临床肝胆病杂志, 2015, 20 (12) :960-968.

[8]BOBERG KM, CHAPMAN RW, HIRSCHFIELD GM, et al.International Autoimmune Hepatitis Group.Overlap syndromes:the international autoimmune hepatitis group (IAIHG) position statement on a controversial issue[J].J Hepatol, 2011, 54 (2) :374-385.

[9]KUIPER EM, ZONDERVAN PE, van BUUREN HR.Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome[J].Clin Gastroenterol Hepatol, 2010, 8 (6) :530-534.

[10]POUPON R, CHAZOUILLERES O, CORPECHOT C, et al.Development of autoimmune hepatitis in patients with typical primary biliary cirrhosis[J].Hepatology, 2006, 44 (1) :85.

[11]SASAKI R, AKIYAMA M, TAKESHITA S, et al.A case of PBC-AIH overlap syndrome who developed AIH 8 years after diagnosis of typical PBC[J].Kanzo, 2009, 50 (50) :445-450.

[12]MANNS MP, CZAJA A J, GORHAM JD, et al.AASLD Practice Guidelines.Diagnosis and management of autoimmune hepatitis[J].Hepatology, 2010, 51 (6) :2193-2213.

[13]HENNES EM, ZENIYA M, CZAJA AJ, et al.Simplified criteria for the diagnosis of autoimmune hepatitis[J].Hepatology, 2008, 48 (1) :169.

[14]CZAJKOWSKI MA, KINGHAM J GC.636 Prevalence and characteristics of overlap syndromes in autoimmune liver disease (AILD) , a twenty-year cohort from a defined community in South Wales[J].J Hepatol, 2006, 44 (Suppl 2) :s236.

[15]PARK Y, CHO Y, CHO EJ, et al.Retrospective analysis of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome in Korea:characteristics, treatments, and outcomes[J].Clin Mol Hepatol, 2015, 21 (2) :150-157.

[16]Chinese Society of Hepatology, Chinese Medical Association;Chinese Society of Gastroenterology, Chinese Medical Association;Chinese Society of Infectious Diseases, Chinese Medical Association.Chinese consensus on the diagnosis and management of autoimmune hepatitis (2015) [J].J Clin Hepatol, 2016, 32 (1) :9-22. (in Chinese) 中华医学会肝病学分会, 中华医学会消化病学分会, 中华医学会感染病学分会.自身免疫性肝炎诊断和治疗共识 (2015) [J].临床肝胆病杂志, 2016, 32 (1) :9-22.

[17]VILLAMIL AG, WELZ G, BANDI JC, et al.556 Overlap syndrome PBC/AIH:prevalence, long term evolution and prognostic factors[J].J Hepatol, 2004, 40 (4) :163.

[18]OWENDUM C.Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome[J].J Hepatol, 2006, 44 (2) :400-406.

[19]DEGOTT C, ZAFRANI ES, CALLARD P, et al.Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression[J].Hepatology, 1999, 29 (4) :1007-1012.

[20]LINDOR KD, GERSHWIN ME, POUPON R, et al.Primary biliary cirrhosis[J].Hepatology, 2009, 50 (1) :291-308.

[21]HEURGUE A, VITRY F, DIEBOLD MD, et al.Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis:a retrospective study of 115 cases of autoimmune liver disease[J].Gastroenterol Clin Biol, 2007, 31 (1) :17-25.

[22]MIAO Q, MA X.Significance of clinical pathology in diagnosis and treatment of autoimmune liver diseases[J].J Clin Hepatol, 2014, 30 (5) :385-389. (in Chinese) 苗琪, 马雄.临床病理学在自身免疫性肝病诊治中的重要性[J].临床肝胆病杂志, 2014, 30 (5) :385-389.

Relative Articles

[1]	Miao Qi, Chen XiaoYu. Liver histopathological diagnosis of autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2020, 36(4): 728-730. doi: 10.3969/j.issn.1001-5256.2020.04.003
[2]	Meng Miao, Hu Zhen, Gong Lei, Lu ZhongHua, Peng XiaoBin, Tang XueJun, Wang XiaoYun. Autoantibody-negative autoimmune hepatitis overlapping with primary biliary cholangitis and primary sclerosing cholangitis: A case report[J]. Journal of Clinical Hepatology, 2019, 35(8): 1806-1808. doi: 10.3969/j.issn.1001-5256.2019.08.032
[3]	Liu HongLi, Yang YongFeng. Clinical and pathological features of primary biliary cholangitis with negative anti-mitochondrial antibody[J]. Journal of Clinical Hepatology, 2019, 35(3): 677-680. doi: 10.3969/j.issn.1001-5256.2019.03.051
[4]	Ye LiHong, Wang ChongKui, Jin Peng, Zhao LiangLiang, Zhang HaiCong, Liu ZhiQuan, Tang YaFang. Clinicopathological features of drug-induced liver injury or primary biliary cholangitis with vanishing bile duct syndrome[J]. Journal of Clinical Hepatology, 2019, 35(2): 359-363. doi: 10.3969/j.issn.1001-5256.2019.02.023
[5]	Shu YanYun, Pan XiaoLi, Song YuHu, Ye Jin. Clinical features of autoimmune hepatitis and primary biliary cholangitis: A comparative analysis[J]. Journal of Clinical Hepatology, 2019, 35(2): 354-358. doi: 10.3969/j.issn.1001-5256.2019.02.022
[7]	Chen YiHua, Wang Chao, Jiang Rui, Tang ShanHong, Luo Yan, Ceng DongMei, He XiaoYan, Shi GuangJing. Pathological features of hepatic epithelioid hemangioendothelioma: An analysis of 5 cases[J]. Journal of Clinical Hepatology, 2018, 34(11): 2356-2359. doi: 10.3969/j.issn.1001-5256.2018.11.017
[8]	Chen Jie, Liu YanMin, Huang ChunYang, Huang YunLi, Zhang XiaoDan, Ren MeiXin, Du XiaoFei, Bian XinQu, Liao HuiYu, Han Ying, Dan Jing. Clinical features of autoimmune hepatitis in children: An analysis of 10 cases[J]. Journal of Clinical Hepatology, 2018, 34(10): 2164-2168. doi: 10.3969/j.issn.1001-5256.2018.10.020
[9]	Wang Yan, Pan Jing, Huo Na, Zhang ZhenZhen, Cheng Hao, Wang GuiQiang. Clinical features of IgG4-associated sclerosing cholangitis: An analysis of 12 cases[J]. Journal of Clinical Hepatology, 2018, 34(6): 1253-1258. doi: 10.3969/j.issn.1001-5256.2018.06.024
[10]	Zhang XiuJun, Lu JianChun, Xue Yuan, Zheng ShuQin, Shi JianGuo. Small bile duct type primary biliary cholangitis mainly presenting as biliary tract infection:a case report[J]. Journal of Clinical Hepatology, 2017, 33(11): 2188-2189. doi: 10.3969/j.issn.1001-5256.2017.11.028
[11]	Gao YanHang, Niu JunQi. EASL-ALEH clinical practice guidelines: non-invasive tests for evaluation of liver disease severity and prognosis[J]. Journal of Clinical Hepatology, 2015, 31(8): 1198-1201. doi: 10.3969/j.issn.1001-5256.2015.08.004
[12]	Chen Li, Zhou XingBei, Wen DanFeng, Wu XueJun, Yang LiJun, Sun Li, Tan YouWen. Clinical features and liver pathology in chronic hepatitis B virus-infected patients with normal liver function[J]. Journal of Clinical Hepatology, 2015, 31(9): 1430-1433. doi: 10.3969/j.issn.1001-5256.2015.09.016
[13]	Gao JiaLin, Yang ZongGuo, Chen XiaoRong, Xu QingNian, Lu YunFei. Analysis of association between HSP70 expression in tumor tissues and clinicopathological characteristics of HBV-related hepatocellular carcinoma[J]. Journal of Clinical Hepatology, 2015, 31(5): 733-736. doi: 10.3969/j.issn.1001-5256.2015.05.024
[14]	Deng YongJun, Xiao MingZhong, Li XiaoDong, Le FengHua, Ni Wei. Clinical characteristics of autoimmune hepatitis: an analysis of 194 patients[J]. Journal of Clinical Hepatology, 2015, 31(9): 1473-1476. doi: 10.3969/j.issn.1001-5256.2015.09.026
[15]	Zhu Zhen, Cong WenMing. Clinicopathological study of intrahepatic bile duct cancers from 1982 to 2011[J]. Journal of Clinical Hepatology, 2013, 29(1): 42-44.
[16]	Chu JinDong, Zhu JiangYi, Gao ZhengJun, Zhu ShaoHua, Dong XuYang, Han ZheYi, Shi YongQuan, Zhou XinMin, Han Ying. Observation of clinical feature and curative efficacy on autoimmune hepatitis-primary biliary cirrhosis overlap syndrome[J]. Journal of Clinical Hepatology, 2012, 28(5): 343-348.
[17]	Lang ZhenWei. Pathological advances in autoimmune liver disease[J]. Journal of Clinical Hepatology, 2012, 28(5): 326-331.
[18]	Duan WeiJia, Jia JiDong. Clinical advances in autoimmune liver disease in 2010[J]. Journal of Clinical Hepatology, 2011, 27(6): 567-569.
[19]	Wang TaiLing, Zhao XinYan. Pathological features of autoimmune hepatitis[J]. Journal of Clinical Hepatology, 2011, 27(6): 577-580.
[20]	Yin FengRong, Zhang Tao. Clinical analysis of 12 cases of primary sclerosing cholangitis[J]. Journal of Clinical Hepatology, 2010, 26(5): 548-550.

Supplements(0)

Cited By

Cited by

Periodical cited type(12)

1.	秦玉洁，周文秀，周兴念，程明亮，李宏. 母女同患原发性胆汁性胆管炎报告并基因分析. 临床肝胆病杂志. 2023(02): 387-391 . 本站查看
2.	蒯君，张兰芳，郭晓鹏，杨芳，杨璐，秦蕾. 醋酸泼尼松片与硫唑嘌呤联合熊去氧胆酸治疗AIH-PBC重叠综合征中期随访研究. 山西卫生健康职业学院学报. 2022(02): 26-27 .
3.	苏杞敏，赵祝香，翁伟镇. 华南地区自身免疫性肝炎-原发性胆汁性胆管炎重叠综合征的临床特点分析. 广州医药. 2022(05): 121-125 .
4.	苏杞敏，王轶，陈慧婷，淦伟强. 122例自身免疫性肝炎-原发性胆汁性胆管炎重叠综合征的临床特点分析. 热带医学杂志. 2021(07): 916-920+949 .
5.	张小雨，严艳. 自身免疫性肝炎合并自身免疫性疾病的特征研究. 医学信息. 2020(02): 89-93 .
6.	倪萍，凡小丽，杨丽. 自身免疫性肝病重叠综合征的研究现状. 临床肝胆病杂志. 2020(04): 743-748 . 本站查看
7.	卢晓霞. 自身免疫性肝炎临床、免疫学及病理学特征分析. 医学食疗与健康. 2020(12): 1+4 .
8.	庞相军，辛桂杰，张娟，闫琪. 原发性胆汁性胆管炎-自身免疫性肝炎重叠综合征合并肝豆状核变性1例报告. 临床肝胆病杂志. 2019(02): 379-381 . 本站查看
9.	张利娟，高银杰，周霞，贺希，冯丹妮，张达利，刘鸿凌. 多发性肌炎误诊为自身免疫性肝病1例报告. 临床肝胆病杂志. 2019(08): 1809-1810 . 本站查看
10.	王静，赵黎莉，石瑞芳，刘勇钢，李嘉. 原发性胆汁性胆管炎/自身免疫性肝炎重叠综合征早期治疗获组织学缓解1例报告. 临床肝胆病杂志. 2019(09): 2059-2061 . 本站查看
11.	孟秀琳. 自身免疫性肝病重叠综合征的诊断和治疗效果体会. 现代养生. 2019(20): 109-110 .
12.	鞠俊玲. 丹东地区42例自身免疫性肝炎误诊为脂肪肝的临床分析. 中国现代药物应用. 2018(23): 38-39 .

Other cited types(3)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (2800) PDF downloads(468)

Clinical and pathological features of autoimmune hepatitis-primary biliary cholangitis overlap syndrome versus autoimmune hepatitis

DOI: 10.3969/j.issn.1001-5256.2017.11.026